Galectin Therapeutics' PIPE - IV Round

Galectin Therapeutics raised a round of funding on February 18, 2008.

Galectin Therapeutics (OTC: PRWP), formerly Pro-Pharmaceuticals, is developing promising carbohydrate-based therapies for fibrotic liver disease and cancer based on the company's unique understanding …

Articles about Galectin Therapeutics' PIPE - IV Round: